Porfimer Sodium Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 75 mg
Reference Brands: Photofrin (USA/EU)
Category:
Oncology Cancer Care
Porfimer sodium is available in Injection
and strengths such as 75 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Porfimer sodium is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Porfimer sodium can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Porfimer sodium, marketed under the brand name Photofrin, is a photosensitizing agent used in photodynamic therapy (PDT) and radiation therapy for the treatment of certain cancers. It is a sodium salt of a mixture of oligomers formed by ether and ester linkages of up to eight porphyrin units. Porfimer is selectively absorbed by tumor cells, where it becomes activated upon exposure to a red light source emitting at 630 nm. Activation produces reactive oxygen species, resulting in cytotoxicity that destroys malignant cells.
In addition to direct tumor cell death, Porfimer may induce ischemic necrosis secondary to vascular occlusion, partially mediated by the release of thromboxane A2. Clinically, it is indicated for the palliative treatment of obstructing endobronchial non-small cell lung carcinoma and obstructing esophageal cancer. The targeted photodynamic mechanism allows Porfimer to minimize damage to surrounding healthy tissue while providing effective tumor control.
Administered as a lyophilized powder for intravenous injection, Porfimer sodium represents a specialized approach to cancer therapy, offering clinicians a tool for both tumor ablation and palliation in patients with advanced or obstructive malignancies. Its unique photodynamic properties make it a valuable addition to oncology treatment regimens.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing